EUVIMEDEUVIMED entdecken
Open Access

Medication misuse and overuse in community‐dwelling persons with dementia

W James Deardorff iD, Bocheng Jing, Matthew E Growdon iD, Kristine Yaffe, W John Boscardin, Kenneth S Boockvar iD, Michael A Steinman iD

Journal of the American Geriatrics Society · 2023

DOI: 10.1111/jgs.18463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2023. Verfasst von W James Deardorff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geriatrics, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Dementia, Prescription Drug Misuse. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NIA NIH HHS, Agency for Healthcare Research and Quality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persons with dementia (PWD) have high rates of polypharmacy. While previous studies have examined specific types of problematic medication use in PWD, we sought to characterize a broad spectrum of medication misuse and overuse among community‐dwelling PWD.

Methods

We included community‐dwelling adults aged ≥66 in the Health and Retirement Study from 2008 to 2018 linked to Medicare and classified as having dementia using a validated algorithm. Medication usage was ascertained over the 1‐year prior to an HRS interview date. Potentially problematic medications were identified by: (1) medication overuse including over‐aggressive treatment of diabetes/hypertension (e.g., insulin/sulfonylurea with hemoglobin A1c < 7.5%) and medications inappropriate near end of life based on STOPPFrail and (2) medication misuse including medications that negatively affect cognition and medications from 2019 Beers and STOPP Version 2 criteria. To contextualize, we compared medication use to people without dementia through a propensity‐matched cohort by age, sex, comorbidities, and interview year. We applied survey weights to make our results nationally representative.

Results

Among 1441 PWD, median age was 84 (interquartile range = 78–89), 67% female, and 14% Black. Overall, 73% of PWD were prescribed ≥1 potentially problematic medication with a mean of 2.09 per individual in the prior year. This was notable across several domains, including 41% prescribed ≥1 medication that negatively affects cognition. Frequently problematic medications included proton pump inhibitors (PPIs), non‐steroidal anti‐inflammatory drugs (NSAIDs), opioids, antihypertensives, and antidiabetic agents. Problematic medication use was higher among PWD compared to those without dementia with 73% versus 67% prescribed ≥1 problematic medication ( p = 0.002) and mean of 2.09 versus 1.62 ( p < 0.001), respectively.

Conclusion

Community‐dwelling PWD frequently receive problematic medications across multiple domains and at higher frequencies compared to those without dementia. Deprescribing efforts for PWD should focus not only on potentially harmful central nervous system‐active medications but also on other classes such as PPIs and NSAIDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaPrescription Drug MisuseAgedHumansFemaleUnited StatesAged, 80 and overMaleIndependent LivingMedicarePotentially Inappropriate Medication ListPolypharmacyAnti-Inflammatory Agents, Non-SteroidalInappropriate Prescribing

Stichwörter der Autor:innen

cognitive impairmentdementiamedication overusepolypharmacypotentially inappropriate medication

Substanzen

Anti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Division of Geriatrics, University of California, San Francisco, San Francisco, California, USA.
  • San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
  • Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: W James Deardorff, Matthew E Growdon, Kenneth S Boockvar, Michael A Steinman

Förderung

  • AHRQ HHS
  • NIA NIH HHS
  • Agency for Healthcare Research and Quality
  • National Institute on Aging

Zitieren

APA

Deardorff, W. J., Jing, B., Growdon, M. E., Yaffe, K., Boscardin, W. J., Boockvar, K. S., & Steinman, M. A. (2023). Medication misuse and overuse in community‐dwelling persons with dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18463

Vancouver

Deardorff WJ, Jing B, Growdon ME, Yaffe K, Boscardin WJ, Boockvar KS, et al. Medication misuse and overuse in community‐dwelling persons with dementia. Journal of the American Geriatrics Society. 2023. doi:10.1111/jgs.18463

BibTeX
@article{Deardorff2023,
  author = {Deardorff, W James and Jing, Bocheng and Growdon, Matthew E and Yaffe, Kristine and Boscardin, W John and Boockvar, Kenneth S and Steinman, Michael A},
  title = {Medication misuse and overuse in community‐dwelling persons with dementia},
  journal = {Journal of the American Geriatrics Society},
  year = {2023},
  doi = {10.1111/jgs.18463}
}
Kostenlos starten →